What is Clinical Research?

Clinical trials are research studies conducted to evaluate medical, surgical, or behavioral interventions. They are the primary way that researchers deter-mine if a new treatment, like a new drug, diet,

or medical device (for example, a pacemaker) is safe and effective
in people. Clinical trials follow strict scientific standards to protect participants and produce reliable study results.

Clinical trials

Clinical trials are categorized
into 4 phases

Brooklyn Clinical primarily conducts Phase II and Phase III trials, while occasionally handling Phase IV

Phase 1

Phase 1

In Phase 1 trials, researchers test a new treatment on a small group of healthy people to see if it’s safe and to find the right dose.

They look for any side effects and study how the body processes the treatment.

Phase 2

Phase 2

Phase 2 trials involve a larger group of people who have the disease or condition that the treatment is meant to address.

In this phase, researchers continue to check for safety and start to see if the treatment actually works. They also work to find the best dose.

Phase 3

Phase 3

In Phase 3 trials, the treatment is given to an even larger group of people. Researchers compare it to existing treatments or placebos to better understand its effectiveness and side effects.

This phase helps gather the necessary information to ensure the treatment can be used safely and possibly get approval from the FDA.

Phase 4

Phase 4

Known as post-marketing trials, Phase 4 occurs after the treatment has been approved by the FDA.

These trials monitor the long-term safety and effectiveness of the treatment in a much larger group of people over a longer period.

Brooklyn Clinical Research, all of the studies conducted are testing drugs made by pharmaceutical companies.

At Brooklyn Clinical Research,
all of the studies conducted are testing drugs made by pharmaceutical companies. In the United States, pharmaceutical companies are not permitted to evaluate whether their own drugs are safe and effective, so a

neutral third-party, such as Brooklyn Clinical, must handle all aspects of testing. This third party has tight restrictions on its financial involvement in the pharmaceutical company and would face substantial criminal penalties for violating these limits.